| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |